Drug recall · February 1, 2023
Clobetasol propionate Cream USP recall
Why: Subpotent Drug: Low assay result observed during long-term stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-956-03
- Lots / codes
Lot#: K101033; Exp 6/2024
- Quantity
- 5720 tubes
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- USA Nationwide
- Initiated
- January 20, 2023 · Voluntary: Firm initiated
- Classified
- January 23, 2023
- Reported
- February 1, 2023
- Ended
- January 16, 2024
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobetasol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.